UK Parliament / Open data

Medical Treatments

Written question asked by Lord Hunt of Kings Heath (Labour) on Thursday, 22 June 2023, in the House of Lords. It was due for an answer on Wednesday, 21 June 2023. It was answered by Lord Markham (Conservative) on Thursday, 22 June 2023 on behalf of the Department of Health and Social Care.

Question

To ask His Majesty's Government, further to the remarks by Lord Markham on 25 May (HL Deb col 1032), whether the National Institute for Health and Care Excellence is currently considering changing the reference case discount rate for costs and health effects that is applied to new health technologies.

Answer

The National Institute for Health and Care Excellence (NICE) is responsible for developing the methods and processes it uses in the development of its guidance, including the discount rate, taking into account its responsibilities under Managing Public Money.

NICE concluded a comprehensive review of its methods and processes in 2022, including consideration of the discount rate. Following public consultation, NICE concluded that it was appropriate to maintain the existing rate of 3.5% due to policy and fiscal implications and interdependencies beyond the scope of the review. The Department and HM Treasury were engaged throughout the review.

NICE is introducing a new modular approach for further methods updates, where it will work with its system partners on the methodological priorities for the healthcare system.

Type
Written question
Reference
HL8289
Session
2022-23
Branded Health Service Medicines (Costs) (Amendment) Regulations 2023
Thursday, 25 May 2023
Proceeding contributions
House of Lords
Grouped for answer
Yes
Back to top